As a policymaker, I would propose legislation on a drug policy for the medically necessary. The drug policy is considerably needed to provide to those patients that are critically ill and could not prolong treatment such as cancer patients, emergency room patients, and intensive care patients. These patients are challenged with a life or death situation, so it is imperative to implement these policies to avoid an incline in mortality rate. If everyone collaborates and follow the policy guidelines, this will reduce but not entirely prevent some of these events from occurring. I would conduct a survey of the healthcare practitioners to obtain feedback and review the FDA update on drug shortages to determine if any current shortages has occurred
